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Cigarette Smoke and Nicotine-Induced Remodeling of Actin Cytoskeleton
and Extracellular Matrix by Vascular Smooth Muscle Cells
Chi-Ming Hai.
Brown University, Providence, RI, USA.
Cigarette smoking is a significant risk factor for atherosclerosis, which involves
the invasion of vascular smooth muscle cells (VSMCs) from the media to in-
tima. Many invasive cells remodel the actin cytoskeleton to form podosomes,
which regulate metalloproteinase (MMP) release for extracellular matrix
(ECM) degradation. We tested the hypothesis that cigarette smoke extract
(CSE) modulates the structure and function of podosomes in VSMCs. We
found that, in response to PKC activation by phorbol dibutyrate (PDBu), un-
treated A7r5 VSMCs formed podosomes, whereas CSE, nicotine, and
carbachol-treated cells formed actin-rich rings. The nicotinic acetylcholine re-
ceptor (nAChR) antagonist a-bungarotoxin abolished the effects of nicotine
and carbachol on actin-rich ring formation. Immunofluorescence labeling ex-
periments localized MMP-2 and nAChRs at the actin-rich rings. Nicotine-
induced actin-rich ring formation required 6-12 hr exposure, and was sensitive
to the protein synthesis inhibitor cycloheximide. Conditioned media collected
from cell culture of nicotine-treated cells induced podosome remodeling in un-
treated cells. When cells were cultured on DQ-gelatin, untreated cells exhibited
a fibrillar network of fluorescence from DQ-gelatin degradation, which, upon
PDBu stimulation, reorganized into peripheral dots and migrated towards the
perinuclear region. In contrast, nicotine-treated cells, upon PDBu stimulation,
reorganized the fluorescence into perinuclear fibrils, which dispersed into small
dots and disappeared rapidly over time. Results from this study suggest that nic-
otine, by activating nAChRs and inducing phenotypic modulation, may prime
VSMCs to become hyperresponsive to PKC activation with an enhanced ability
to remodel the actin cytoskeleton and release MMP for invasion of the ECM.
This study was supported by NIH grant HL-52714.
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Bupropion Binds in the Middle (M2-9) of the Torpedo Nicotinic Acetylcho-
line Receptor Ion Channel
Akash Pandhare1, Ayman K. Hamouda2, Brandon Staggs1,
Phaneendra K. Duddempudi1, John R. Lever3,4, Jonathan B. Cohen2,
David J. Lapinsky5, Michaela Jansen1, Michael P. Blanton1.
1Texas Tech University Health Sciences Center, Lubbock, TX, USA,
2Harvard Medical School, Boston, MA, USA, 3University of Missouri,
Columbia, MO, USA, 4Harry S. Truman Veterans Administration Medical
Center, Columbia, MO, USA, 5Duquesne University, Pittsburgh, PA, USA.
Bupropion is clinically prescribed for the treatment of depression (Wellbutrin)
and for smoking cessation (Zyban). While there is consensus that the primary
mechanism of action involves increased synaptic concentrations of dopamine
and norepinephrine via inhibition of the respective reuptake transporters,
DAT and NET, there is growing evidence that some of the therapeutic benefits
of bupropion may result from non-competitive antagonism of neuronal nico-
tinic acetylcholine receptors (nAChRs), in particular a4b2 and a3b4 subtypes.
To aid in elucidating the mechanism of bupropion action and the development
of new therapeutic agents for smoking cessation and depression, our goal is to
determine the specific molecular interactions between bupropion and several
nAChR subtypes (Torpedo, a4b2, a3b4). We first established that bupropion
dose-dependently and reversibly inhibits ACh-induced currents in Xenopus lae-
vis oocytes injected with affinity-purified and lipid-reconstituted Torpedo
nAChRs (IC50 0.34 mM). Using a photoreactive analog of bupropion ([
125I]-
SADU-3-72), we next established that bupropion inhibits the binding of
[125I]-SADU-3-72 to the Torpedo nAChR (IC50 closed state, 3.6 mM; desensi-
tized state, 1.2 mM) and that binding to the closed nAChR is fully inhibited by
tetracaine (IC50 0.42 mM) consistent with a bupropion/[
125I]-SADU-3-72 bind-
ing site within the nAChR channel. [125I]-SADU-3-72 photolabeled Torpedo
nAChR subunits in an agonist-sensitive and bupropion-inhibitable (specific)
manner. Finally for the closed nAChR, we identified sites of specific [125I]-
SADU-3-72 labeling within dM2 (dLeu265/dM2-9) and bM2 (bLeu257/
bM2-9). In the desensitized state, TCP-inhibitable (specific) labeling was iden-
tified within dM2 (dLeu265, dM2-9 with minor labeling of dSer258, dM2-2).
Our results establish that bupropion binds in the middle (M2-9) of the Torpedo
nAChR channel, with a slightly broader binding locus in the desensitized chan-
nel. Currently, studies are underway to identify the site(s) of [125I]-SADU-3-72
labeling in affinity-purified a4b2 and a3b4 nAChRs.
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Injection of Affinity-Purified Ligand-Gated Ion Channels into Xenopus
Laevis Oocytes for Functional Studies using Electrophysiology
Akash Pandhare, Michaela Jansen, Michael P. Blanton.
Texas Tech University Health Sciences Center, Lubbock, TX, USA.Heterologous expression after mRNA/cDNA injection into Xenopus oocytes is
a well established system for studying the structure and function of a variety of
membrane proteins including ligand-gated ion channels (LGIC). In the early
1990’s, the Miledi group [1] introduced a rather unique variant of this system
by injecting pre-assembled nicotinic acetylcholine receptors (nAChR) into oo-
cytes and measuring function using electrophysiological recordings. Native or
affinity-purified Torpedo nAChR-membranes were injected into Xenopus oo-
cytes and after incubation to allow receptor-containing membranes to fuse
with the plasma membrane, functional receptor channels were detected using
two-electrode voltage clamp recordings. Our goal is to utilize this system to as-
sess the functionality and pharmacology of affinity-purified and lipid-
reconstituted LGICs. We first determined that the optimal incubation period
for the appearance of maximal functional channels following injection of native
or affinity-purified and lipid-reconstituted Torpedo nAChRs was 48 hr. We next
established that injection of affinity-purified Torpedo nAChRs reconstituted in
lipid vesicles comprised of only phosphatidylcholine (DOPC) had minimal
functionality (300 mM i.e. >EC100 ACh-induced currents at 60 mV; ~ 13-
23 nA). In contrast, affinity-purified Torpedo nAChRs reconstituted in vesicles
comprised of DOPC/DOPA/CH (3:1:1) were fully functional (300 mM ACh at
60 mV; ~ 1-3 mA) and the EC50 for ACh (~ 50 mM) was comparable to that
obtained for Torpedo nAChR mRNA injected oocytes. These results indicate
that CH and anionic lipids (PA) are not only required for receptor functionality
[2] but are protective of receptors during detergent solubilization and affinity-
purification. Currently, studies are underway to examine the functionality of
several affinity-purified and lipid-reconstituted LGICs, including a4b2 and
a3b4 nAChRs, and 5-HT3A receptors.
[1] Marsal et al (1995) PNAS 92, 5224-5228.
[2] Hamouda et al (2006) Biochemistry 45, 4327-4337.
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Sources of Energy for Gating by Agonists in Acetylcholine Receptor-
Channels
Iva Bruhova, Prasad Purohit, Anthony Auerbach.
State University of New York at Buffalo, Buffalo, NY, USA.
The neuromuscular acetylcholine receptor (AChR) is an allosteric protein that
switches between closed- and open-channel conformations. The probability of
being open increaseswhen acetylcholine (ACh)molecules occupy the two trans-
mitter binding sites (TBS). Based on the MWC model and experimental mea-
sures of the di- and unliganded gating equilibrium constants (E2 and E0), we
estimate the energy that an agonist provides to power gating is =0.59ln(O(E2/
E0)). In wt adult neuromuscular AChRs, each ACh provides ~-5.1 kcal/mol. The
question we asked is: which TBS residues provide this energy? Using single-
channel electrophysiology, we examined four aromatic residues in thea subunit,
Y93, W149, Y190, and Y198. Mutation to Phe caused small (<1 kcal/mol) re-
ductions in energy at positions 93, 149, and 198, but a large reduction effect at
190. The removal of aromatic ring by Ala mutation caused large (>2 kcal/
mol) reductions at positions 149, 190, and 198, but not 93. These results suggest
that 149 and 198 interact with ACh mainly through the aromatic ring, not H-
bonding. Mutations of 190 to F, W, and A had the largest reductions (2.2-4.5
kcal/mol), so this residue provides most of the energy. In contrast, 93 is much
weaker as mutations to F, W, H, A, C, S, and G reduced the energy %1.1
kcal/mol. Overall, the order of energy loss was 190>>149>198>93. The
sum of the Ala mutant energy reductions for the four positions was >5.1 kcal/
mol, suggesting that these side chains interact energetically. We created double
mutant F-F constructs (n=6) and observed significant coupling (>1.5 kcal/mol)
between 190-93, 190-149, and 190-198, but little coupling between the other
pairs. Thus, 190 not only provides most of the energy for gating, but is also cou-
pled with the surrounding aromatic TBS residues. Supported by CIHR and NIH.
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Effects of Lipid-Analog Detergent Solubilization on the Functionality and
Lipidic Cubic Phase Mobility of the Torpedo Californica Nicotinic Acetyl-
choline Receptor
Luis F. Padilla-Morales1, Pamela C. De La Cruz-Rivera1,
Claudio L. Morales-Perez1, Guillermo Asmar-Rovira2,
Carlos A. Baez-Pagan1, Orestes Quesada1, Jose A. Lasalde-Dominicci1.
1University of Puerto Rico Rı´o Piedras, San Juan, Puerto Rico,
2Scripps Research Institute, La Jolla, CA, USA.
Over the past three decades, the Torpedo californica nicotinic acetylcholine re-
ceptor (nAChR) has been one of the most extensively studied membrane pro-
tein systems. However, the effects of detergent solubilization on nAChR
resistance to degradation and function are poorly understood. The use of
lipid-analog detergents for nAChR solubilization has been shown to preserve
receptor integrity and functionality. The present study used lipid-analog deter-
gents from phospholipid-analog and cholesterol-analog detergent families for
solubilization and affinity purification of the receptor and probed nAChR ion
Sunday, February 26, 2012 119achannel function using planar lipid bilayers (PLBs) and integrity using analyt-
ical size exclusion chromatography (A-SEC) in the detergent-solubilized state.
We also examined receptor mobility on the lipidic cubic phase (LCP) by mea-
suring nAChR mobile fraction and diffusion coefficient through fluorescence
recovery after photobleaching (FRAP) experiments using lipid-analog and
non-lipid-analog detergents. Our results show that it is possible to isolate stable
and functional nAChRs using lipid-analog detergents, with characteristic ion
channel currents in PLBs and minimal aggregation as observed in A-SEC. Fur-
thermore, fractional mobility and diffusion coefficient values observed in
FRAP experiments were similar to the values observed for these parameters
in the recently LCP-crystallized ß2-adrenergic receptor. The overall results
show that phospholipid-analog detergents with 16 carbon acyl-chains support
nAChR integrity, functionality, and LCP mobility.
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X-Ray Structures of General Anaesthetics Bound to a Pentameric Ligand-
Gated Ion Channel
Hugues Nury1, Catherine Van Renterghem1, Yun Weng2, Alfonso Tran2,
Marc Baaden3, Virginie Dufresne1, Jean-Pierre Changeux1, Jim Sonner2,
Marc Delarue1, Pierre-Jean Corringer1.
1Institut Pasteur, Paris, France, 2UCSD, San Francisco, CA, USA,
3CNRS, Paris, France.
General anaesthetics have enjoyed long and widespread use but their molecular
mechanism of action remains poorly understood. There is good evidence that
their principal targets are pentameric ligand-gated ion channels (pLGICs) such
as inhibitory GABAA (g-aminobutyric acid) receptors and excitatory nicotinic
acetylcholine receptors, which are respectively potentiated and inhibited by
general anaesthetics. The bacterial homologue from Gloeobacter violaceus
(GLIC), whose X-ray structure was recently solved, is also sensitive to clinical
concentrations of general anaesthetics. Here we describe the crystal structures of
the complexes propofol/GLIC and desflurane/GLIC. These reveal a common
general-anaesthetic binding site, which pre-exists in the apo-structure in the
upper part of the transmembrane domain of each protomer. Both molecules
establish van der Waals interactions with the protein; propofol binds at the
entranceof the cavitywhereas the smaller,more flexible, desfluranebinds deeper
inside. Mutations of some amino acids lining the binding site profoundly alter
the ionic response ofGLIC to protons, and affect its general-anaesthetic pharma-
cology. Molecular dynamics simulations, performed on the wild type and two
GLIC mutants, highlight differences in mobility of propofol in its binding site
and help to explain these effects. These data provide a novel structural frame-
work for the design of general anaesthetics and of allosteric modulators of brain
pLGICs.
NuryH,VanRenterghemC,WengY,TranA,DufresneV,BaadenM,Changeux
JP, Sonner JM, Delarue M, Corringer PJ. Nature 469, 428-431 (2011).
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New Estimates for the ‘Allosteric’ Constant of Neuromuscular Acetylcho-
line Receptor-Channels
Tapan K. Nayak, Prasad Purohit, Anthony Auerbach.
SUNY @ Buffalo, Buffalo, NY, USA.
Nicotinic acetylcholine receptors (AChRs) open rarely in the absence of agonists
but many different mutations substantially increase the unliganded gating equilib-
rium constant (the ‘allosteric’ constant, E0). In the adult mouse neuromuscular
AChR a single mutation, ‘Special character’ A96H (in both ‘Special character’
subunits), increased E0 by >10
5-fold and caused spontaneous openings to occur
in clusters arising from individual receptors. We measured E0 for three different
sets of mutant combinations and by extrapolation estimated E0 for wild type
AChRs. The estimates were E0
wt=6.0x107 and 7.4 x 107 in adult-type AChRs
and 4.3x107 in fetal-type AChRs (100 mV, 23 oC). The adult value is in excel-
lent agreement with one obtained previously by using a completely different
method (6.6x107, from monoliganded gating). We found that E0
wt decreased e-
fold with a ~58 mV depolarization, and that Naþ and Kþ in the extracellular solu-
tion had no effect on E0. However, Cs
þ acted as a very weak ‘partial’ agonist. The
results are discussed with regard to the energetics of receptor activation and the
competitive antagonism of ions with regard to agonist binding.
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Identification of Amino Acid Residues that Prevent Efficient Binding of 4/7
a-Conotoxins to Nicotinic a4b2 Receptor Subtypes
Mirko Beissner1, Se´bastien Dutertre2, Rudolf Schemm3, Timm Danker4,
Annett Sporning5, Annette Nicke5.
1MPI for Brain Research, Frankfurt, Germany, 2Institute for Molecular
Biosciences, Brisbane, Australia, 3MPI for Biophysical Chemistry,
Go¨ttingen, Germany, 4NMI Technologie Transfer GmbH, Reutlingen,
Germany, 5MPI for Experimental Medicine, Go¨ttingen, Germany.a-Conotoxins are nAChR antagonists with high subtype selectivity. Several
potent a3b2 nAChR-selective a-contoxins have been identified. However,
most characterized a-conotoxins show no or only weak affinity for the a4b2
nAChR subtype. In this study, we constructed homology models of a3b2 and
a4b2 ligand binding domains and substituted selected amino acid residues in
the a4 subunit by the respective residues in the a3 subunit to identify the
determinants of subtype selectivity. Characterization of these mutants by
two-electrode voltage-clamp analysis identified two mutants, a4R185I and
a4P195Q, that exhibited increased affinity for several a-conotoxins. Replace-
ment of a4R185 by alanine or glutamate but not by lysine also increased a-con-
otoxin affinity, indicating that a positive charge in this position interferes with
a-conotoxin binding. Docking studies and molecular dynamic simulations
supported our findings and further demonstrated that residues R185 and P195
inhibit a close contact of the C-loop with a-conotoxins and thus prevent high
affinity binding.
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On the Complexity of the Kinetics of Unliganded Gating in Neuromuscular
Acetylcholine Receptor-Channels
Prasad G. Purohit, Anthony Auerbach.
Suny Buffalo, Buffalo, NY, USA.
The magnitude of an agonist-induced response depends on both the intrinsic
tendency of the unliganded receptor to open and the amount of agonist binding
energy realized in the channel-opening process. It is easy to make mouse neu-
romuscular acetylcholine receptors (AChRs) open in the absence of agonist by
making a small number of mutations (cell attached, HEK cells, 100 mV).
However, the single-channel, unliganded gating kinetics for an individual
AChR is complex and show multiple closed and open components (3C, 2O).
We have found that many perturbations (in the vicinity of the transmitter bind-
ing site) increase or decrease this complexity. Mutations at positions aA96,
aG153, aF189, or εP121(dP123) increase the probability of longer openings,
as does the presence of extracellular Csþ. Agonists and most mutations at po-
sitions aY93, aG147, aW149, aY190 or aY198 greatly reduce these events.
We compared log-likelihood values for all possible 3C-2O kinetic schemes
(without cycles) and found that four of these consistently produced
equivalently-high scores. However, only some were able to reproduce the rapid
rising phase of the synaptic response apparent under normal physiological con-
ditions. Although we as yet do not have an understanding of the structural
basis for the kinetic complexity, the results suggest that without ligands there
is a conformational flexibility at the binding site that is absent with ligands.
The malleability of unliganded gating kinetics further suggests that many
binding site residues can influence this flexibility. Supported by NS-23513
and NS-64969.
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Effects of Mutations of Proline Residues Located in the Complementary
Subunit of the Acetylcholine Receptor Transmitter Binding Site
Shaweta Gupta, Prasad Purohit, Anthony Auerbach.
University at Buffalo, Buffalo, NY, USA.
Nicotinic acetylcholine receptor-channels (AChRs) are allosteric proteins that
isomerize between a non-conducting/low-affinity and a conducting/high-
affinity conformation. Each neuromuscular AChR has two transmitter binding
sites located at the interface between adjacent subunits (a
ε
or ad.We studied the
gating properties of AChRs with mutations at the vicinal prolines located at
these interfaces. In both cases, mutations of the N-terminal residue had little
effect but those of the C-terminal residue (εP121 or dP123) decreased substan-
tially the open channel probability (500 mM ACh). We estimated the unli-
ganded (E0) and diliganded (E2) gating equilibrium constants for mutations
of these two prolines from single-channel currents (30 mM ACh, þ100mV).
All of the tested substitutions decreased both gating constants. The slope of
the rate-equilibrium plot (F)for εP121/dP123 was ~0.96 (diliganded) and
~0.70 (unliganded). Some of the mutations caused a large decrease in the
closed/open equilibrium dissociation constant ratio for ACh (lACh) while
others had more modest effects. Probing the effects of εP121 and dP123 muta-
tions should allow an estimation of the binding and gating properties of each of
the two transmitter binding sites, separately.
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Introducing Kappa: An Integrated, ‘Catch-And-Hold’ Reaction Co-
Ordinate that Triggers AChR Gating
Snehal V. Jadey, Anthony Auerbach.
State University at New York at Buffalo, Buffalo, NY, USA.
For many years drug action on membrane receptors has been conceptualized as
occurring in two distinct steps, initially termed ‘affinity’ and ‘intrinsic activity’.
In ligand-gated ion channels these stages of activation are called ‘binding’ and
‘gating’. Single-channel kinetic analysis of adult-type mouse neuromuscular
